Article Details

Open Orphan wins £5m RSV human challenge study contract with European biotechnology company

Retrieved on: 2022-03-25 07:22:46

Tags for this article:

Click the tags to see associated articles and topics

Open Orphan wins £5m RSV human challenge study contract with European biotechnology company. View article details on hiswai:

Excerpt

... contract with a European biotechnology company to test its intravenous antiviral candidate, using the hVIVO RSV Human Challenge Study Model.

Article found on: www.directorstalkinterviews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up